Advertisement
Screener

SYROS PHARMACEUTICALS, INC. Operating Cash Flow

SYROS PHARMACEUTICALS, INC. Operating Cash Flow

SYROS PHARMACEUTICALS, INC. reported Operating Cash Flow of -$81.45 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-10-31

  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$20.69M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$29.67M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$31.10M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$18.56M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$109.71M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$123.06M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$99.54M.
  • SYROS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$57.36M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2024-09-30-$20.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$50.36M
derived: sum of 2 quarters · filed 2024-10-31
-$81.45M
10-Q · filed 2024-10-31
-$100.02M
derived: sum of 4 quarters · filed 2024-10-31
2024-06-30-$29.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$60.77M
10-Q · filed 2024-07-31
-$79.33M
derived: sum of 3 quarters · filed 2024-07-31
-$111.19M
derived: sum of 4 quarters · filed 2024-10-31
2024-03-31-$31.10M
10-Q · filed 2024-05-14
-$49.66M
derived: sum of 2 quarters · filed 2024-05-14
-$81.52M
derived: sum of 3 quarters · filed 2024-10-31
-$103.90M
derived: sum of 4 quarters · filed 2024-10-31
2023-12-31-$18.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
-$50.42M
derived: sum of 2 quarters · filed 2024-10-31
-$72.81M
derived: sum of 3 quarters · filed 2024-10-31
-$109.71M
10-K · filed 2024-03-27
2023-09-30-$31.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$54.24M
derived: sum of 2 quarters · filed 2024-10-31
-$91.14M
10-Q · filed 2024-10-31
-$122.23M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30-$22.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$59.29M
10-Q · filed 2024-07-31
-$90.37M
derived: sum of 3 quarters · filed 2024-07-31
-$126.16M
derived: sum of 4 quarters · filed 2024-07-31
2023-03-31-$36.90M
10-Q · filed 2024-05-14
-$67.98M
derived: sum of 2 quarters · filed 2024-05-14
-$103.77M
derived: sum of 3 quarters · filed 2024-05-14
-$129.95M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$31.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
-$66.87M
derived: sum of 2 quarters · filed 2024-03-27
-$93.05M
derived: sum of 3 quarters · filed 2024-03-27
-$123.06M
10-K · filed 2024-03-27
2022-09-30-$35.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$61.97M
derived: sum of 2 quarters · filed 2023-11-14
-$91.98M
10-Q · filed 2023-11-14
-$114.95M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$26.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$56.20M
10-Q · filed 2023-08-08
-$79.16M
derived: sum of 3 quarters · filed 2023-08-08
-$107.29M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$30.02M
10-Q · filed 2023-05-10
-$52.99M
derived: sum of 2 quarters · filed 2023-05-10
-$81.11M
derived: sum of 3 quarters · filed 2023-05-10
-$107.57M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$22.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
-$51.10M
derived: sum of 2 quarters · filed 2023-03-02
-$77.55M
derived: sum of 3 quarters · filed 2023-03-02
-$99.54M
10-K · filed 2023-03-02
2021-09-30-$28.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$54.58M
derived: sum of 2 quarters · filed 2022-11-14
-$76.57M
10-Q · filed 2022-11-14
-$106.50M
derived: sum of 4 quarters · filed 2023-03-02
2021-06-30-$26.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$48.44M
10-Q · filed 2022-08-09
-$78.37M
derived: sum of 3 quarters · filed 2023-03-02
-$93.62M
derived: sum of 4 quarters · filed 2023-03-02
2021-03-31-$21.99M
10-Q · filed 2022-05-16
-$51.91M
derived: sum of 2 quarters · filed 2023-03-02
-$67.17M
derived: sum of 3 quarters · filed 2023-03-02
-$79.60M
derived: sum of 4 quarters · filed 2023-03-02
2020-12-31-$29.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
-$45.18M
derived: sum of 2 quarters · filed 2023-03-02
-$57.61M
derived: sum of 3 quarters · filed 2023-03-02
-$57.36M
10-K · filed 2023-03-02
2020-09-30-$15.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$27.69M
derived: sum of 2 quarters · filed 2021-11-05
-$27.44M
10-Q · filed 2021-11-05
-$38.04M
derived: sum of 4 quarters · filed 2022-03-15
2020-06-30-$12.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$12.19M
10-Q · filed 2021-08-05
-$22.79M
derived: sum of 3 quarters · filed 2022-03-15
-$34.01M
derived: sum of 4 quarters · filed 2022-03-15
2020-03-31$246.00K
10-Q · filed 2021-05-06
-$10.36M
derived: sum of 2 quarters · filed 2022-03-15
-$21.58M
derived: sum of 3 quarters · filed 2022-03-15
-$39.68M
derived: sum of 4 quarters · filed 2022-03-15
2019-12-31-$10.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
-$21.83M
derived: sum of 2 quarters · filed 2022-03-15
-$39.93M
derived: sum of 3 quarters · filed 2022-03-15
-$60.25M
10-K · filed 2022-03-15
2019-09-30-$11.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$29.32M
derived: sum of 2 quarters · filed 2020-11-05
-$49.65M
10-Q · filed 2020-11-05
-$63.46M
derived: sum of 4 quarters · filed 2021-03-04
2019-06-30-$18.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$38.43M
10-Q · filed 2020-08-06
-$52.24M
derived: sum of 3 quarters · filed 2021-03-04
-$62.26M
derived: sum of 4 quarters · filed 2021-03-04
2019-03-31-$20.33M
10-Q · filed 2020-05-07
-$34.14M
derived: sum of 2 quarters · filed 2021-03-04
-$44.16M
derived: sum of 3 quarters · filed 2021-03-04
-$58.24M
derived: sum of 4 quarters · filed 2021-03-04
2018-12-31-$13.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04
-$23.84M
derived: sum of 2 quarters · filed 2021-03-04
-$37.91M
derived: sum of 3 quarters · filed 2021-03-04
-$40.31M
10-K · filed 2021-03-04
2018-09-30-$10.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$24.10M
derived: sum of 2 quarters · filed 2019-11-12
-$26.50M
10-Q · filed 2019-11-12
-$37.07M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30-$14.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$16.48M
10-Q · filed 2019-08-01
-$27.05M
derived: sum of 3 quarters · filed 2020-03-05
-$36.58M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31-$2.40M
10-Q · filed 2019-05-01
-$12.97M
derived: sum of 2 quarters · filed 2020-03-05
-$22.50M
derived: sum of 3 quarters · filed 2020-03-05
-$34.31M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31-$10.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
-$20.10M
derived: sum of 2 quarters · filed 2020-03-05
-$31.91M
derived: sum of 3 quarters · filed 2020-03-05
-$44.73M
10-K · filed 2020-03-05
2017-09-30-$9.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$21.34M
derived: sum of 2 quarters · filed 2018-11-01
-$34.16M
10-Q · filed 2018-11-01
-$43.76M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30-$11.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$24.63M
10-Q · filed 2018-08-07
-$34.23M
derived: sum of 3 quarters · filed 2019-03-07
-$43.40M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$12.82M
10-Q · filed 2018-05-10
-$22.42M
derived: sum of 2 quarters · filed 2019-03-07
-$31.59M
derived: sum of 3 quarters · filed 2019-03-07
2016-12-31-$9.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$18.77M
derived: sum of 2 quarters · filed 2019-03-07
-$40.54M
10-K · filed 2019-03-07
2016-09-30-$9.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$30.94M
10-Q · filed 2017-11-08
2016-06-30-$21.77M
10-Q · filed 2017-08-09
2015-12-31-$23.03M
10-K · filed 2018-03-12